Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about POLG: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
POLG is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, therapeutic target. Associated with ALS, Aging, Als. Connected to 147 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | POLG |
| Full Name | DNA Polymerase Subunit Gamma |
| Chromosome | 15q25 |
| Protein Type | Tissues Affected |
| Function | POLG is the catalytic engine of the mitochondrial DNA replication machinery, one of the essential components of the mtDNA replisome that includes the helicase TWNK (Twinkle), the single-stranded DNA-b |
| Molecular Weight | 140 kDa |
| Amino Acids | 1239 aa |
| Pathways | Mitophagy |
| UniProt ID | Q9UQF2 |
| NCBI Gene ID | 5428 |
| Ensembl ID | ENSG00000140521 |
| OMIM | 174763 |
| GeneCards | POLG |
| Human Protein Atlas | POLG |
| Associated Diseases | Aging, Als, Alzheimer's disease, Ataxia, Bipolar |
| Interactions | ALOX, AND, APOPTOSIS, App, ATG, BAX |
| KG Connections | 264 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
POLG["POLG
Mitochondrial DNA
Polymerase gamma"]
MTDNA["MTDNA
Mitochondrial DNA
Replication"]
DNA_REP["DNA Repair
and Maintenance"]
MITO_DYSFUNC["Mitochondrial
Dysfunction"]
AUTOPHAGY["Autophagy
Pathway"]
FERROPTOSIS["Ferroptosis
Pathway"]
ATM["ATM
DNA Damage
Response"]
STING1["STING1
Innate Immunity
Signaling"]
SLC7A11["SLC7A11
Cystine/Glutamate
Antiporter"]
CIRCADIAN["Circadian Rhythm
Regulation"]
PARKINSON["Parkinson's
Disease"]
ALS["Amyotrophic
Lateral Sclerosis"]
MS["Multiple
Sclerosis"]
NEURODEGENERATION["Neurodegeneration
Outcomes"]
OXIDATIVE["Oxidative Stress
and Cell Death"]
POLG -->|"replicates"| MTDNA
POLG -->|"maintains"| DNA_REP
MTDNA -->|"dysfunction"| MITO_DYSFUNC
MITO_DYSFUNC -->|"triggers"| OXIDATIVE
POLG -->|"activates"| FERROPTOSIS
POLG -->|"associated with"| AUTOPHAGY
POLG -->|"interacts with"| ATM
POLG -->|"signals through"| STING1
POLG -->|"regulates"| SLC7A11
POLG -->|"influences"| CIRCADIAN
OXIDATIVE -->|"leads to"| PARKINSON
OXIDATIVE -->|"leads to"| ALS
OXIDATIVE -->|"leads to"| MS
FERROPTOSIS -->|"contributes to"| NEURODEGENERATION
PARKINSON -->|"part of"| NEURODEGENERATION
ALS -->|"part of"| NEURODEGENERATION
MS -->|"part of"| NEURODEGENERATION
style POLG fill:#006494
style AUTOPHAGY fill:#1b5e20
style ATM fill:#4a1a6b
style STING1 fill:#4a1a6b
style SLC7A11 fill:#4a1a6b
style CIRCADIAN fill:#4a1a6b
style FERROPTOSIS fill:#ef5350
style MITO_DYSFUNC fill:#ef5350
style OXIDATIVE fill:#ef5350
style PARKINSON fill:#5d4400
style ALS fill:#5d4400
style MS fill:#5d4400
style NEURODEGENERATION fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| mtDNA | involved_in | compound | 0.85 |
| mtDNA | regulates | compound | 0.80 |
| Intestinal Barrier Disruption | causes | phenotype | 0.80 |
| Als | associated_with | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Ataxia | associated_with | disease | 0.75 |
| DNA | activates | gene | 0.70 |
| Oxidative Stress | activates | pathway | 0.70 |
| Mood Disorder | associated_with | disease | 0.70 |
| OXIDATIVE STRESS | activates | gene | 0.70 |
| MITOCHONDRIAL DNA | activates | gene | 0.70 |
| DNA | associated_with | gene | 0.70 |
| parkinsonism | associated_with | disease | 0.70 |
| MITOCHONDRIAL DYSFUNCTION | associated_with | gene | 0.70 |
| Neurodegeneration | activates | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Schizophrenia | associated_with | disease | 0.65 |
| Depression | associated_with | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Bipolar | associated_with | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Aging | expressed_in | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Neuropathy | expressed_in | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Apoptosis | activates | pathway | 0.60 |
| Oxidative Phosphorylation | activates | pathway | 0.60 |
| Mitophagy | regulates | pathway | 0.60 |
| Glycolysis | activates | pathway | 0.60 |
| MITOCHONDRIAL DNA | associated_with | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| MITOCHONDRIA | associated_with | gene | 0.60 |
| RNF216 | associated_with | gene | 0.60 |
| HTR2A | associated_with | gene | 0.60 |
| STING1 | activates | entity | 0.60 |
| TFAM | activates | entity | 0.60 |
| TMEM173 | activates | entity | 0.60 |
| NCOA4 | associated_with | gene | 0.60 |
| DAO | associated_with | gene | 0.60 |
| NRG1 | associated_with | gene | 0.60 |
| RGS4 | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ROS | associated_with | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| MITOPHAGY | regulates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| MAP1LC3B | associated_with | gene | 0.60 |
| GPX4 | associated_with | gene | 0.60 |
| BMAL1 | associated_with | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| NCOA4 | associated_with | gene | 0.60 |
| ARNTL | associated_with | gene | 0.60 |
| CGAS | associated_with | gene | 0.60 |
| SLC7A11 | associated_with | gene | 0.60 |
| TMEM173 | associated_with | gene | 0.60 |
| FANCD2 | associated_with | gene | 0.60 |
| STING1 | associated_with | gene | 0.60 |
| TFAM | associated_with | gene | 0.60 |
| BAX | activates | gene | 0.60 |
| POLG2 | associated_with | gene | 0.60 |
| SLC25A4 | associated_with | gene | 0.60 |
| MFN2 | associated_with | gene | 0.60 |
| TYMP | associated_with | gene | 0.60 |
| RRM2B | associated_with | gene | 0.60 |
| TK2 | associated_with | gene | 0.60 |
| SUCLA2 | associated_with | gene | 0.60 |
| SUCLG1 | associated_with | gene | 0.60 |
| PNPLA6 | associated_with | gene | 0.60 |
| DEPRESSION | associated_with | gene | 0.60 |
| CIRCADIAN RHYTHM | associated_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| MITOCHONDRIAL DNA | expressed_in | gene | 0.60 |
| AND | contributes_to | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| MTDNA | expressed_in | gene | 0.60 |
| AGING | expressed_in | gene | 0.60 |
| DNA | expressed_in | gene | 0.60 |
| TRPM2 | associated_with | gene | 0.60 |
| GRM3 | associated_with | gene | 0.60 |
| PINK1 | therapeutic_target | gene | 0.60 |
| PARKIN | associated_with | gene | 0.60 |
| LRRK2 | therapeutic_target | gene | 0.60 |
| NEURODEGENERATION | therapeutic_target | gene | 0.60 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.60 |
| ALPHA-SYNUCLEIN | therapeutic_target | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| ALOX | activates | gene | 0.60 |
| ATG | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| HTR2A | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning POLG in their description or question text
No additional research found